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RESEARCH ARTICLE
Does Breast Cancer Drive the Building of Survival Probability
Models among States? An Assessment of Goodness of Fit for
Patient Data from SEER Registries
Hafiz Khan1*, Anshul Saxena2, Abhilash Perisetti3, Aamrin Rafiq4, Kemesha
Gabbidon3, Sarah Mende1, Maria Lyuksyutova3, Kandi Quesada1, Summre
Blakely1, Tiffany Torres1, Mahlet Afesse1
Abstract
Background: Breast cancer is a worldwide public health concern and is the most prevalent type of cancer in women
in the United States. This study concerned the best fit of statistical probability models on the basis of survival times
for nine state cancer registries: California, Connecticut, Georgia, Hawaii, Iowa, Michigan, New Mexico, Utah, and
Washington. Materials and Methods: A probability random sampling method was applied to select and extract records
of 2,000 breast cancer patients from the Surveillance Epidemiology and End Results (SEER) database for each of the
nine state cancer registries used in this study. EasyFit software was utilized to identify the best probability models by
using goodness of fit tests, and to estimate parameters for various statistical probability distributions that fit survival
data. Results: Statistical analysis for the summary of statistics is reported for each of the states for the years 1973 to
2012. Kolmogorov-Smirnov, Anderson-Darling, and Chi-squared goodness of fit test values were used for survival
data, the highest values of goodness of fit statistics being considered indicative of the best fit survival model for each
state. Conclusions: It was found that California, Connecticut, Georgia, Iowa, New Mexico, and Washington followed
the Burr probability distribution, while the Dagum probability distribution gave the best fit for Michigan and Utah,
and Hawaii followed the Gamma probability distribution. These findings highlight differences between states through
selected sociodemographic variables and also demonstrate probability modeling differences in breast cancer survival
times. The results of this study can be used to guide healthcare providers and researchers for further investigations into
social and environmental factors in order to reduce the occurrence of and mortality due to breast cancer.
Keywords: Breast cancer data- survival- probability models- goodness of fit tests
Asian Pac J Cancer Prev, 17 (12), 5287-5294

Introduction
Cancer has adversely affected the lives of many
individuals, resulting in high mortality and morbidity
rates. Currently, cancer is the second leading cause of
death in the United States, preceded only by heart disease.
However, it is expected to become the top leading cause
of death within the next few years (Siegel et al., 2015).
Despite declines in the incidence of prostate and lung
cancer, breast cancer rates have remained relatively stable.
Today there are more than three million women living in
the US with a history of invasive breast cancer (Siegel
et al., 2013). Moreover, it is estimated that one in eight
women living in the US will develop breast cancer in her
lifetime (DeSantis et al., 2014).
In most instances the risk of developing cancer
increases with age. Out of all women who have been
diagnosed with breast cancer in the US, 40% of breast

cancer cases occurred among women over age 65 and
another 20% among women under age 50 (Siegel et al.,
2013). It is estimated that 1 in 53 women ages 0-49 will
be diagnosed with breast cancer, as well as 1 in 44 women
ages 50-59, 1 in 29 women ages 60 to 69, and 1 in 15
women over 70 (Iqbal et al., 2015; Kwan et al., 2014;
Siegel et al, 2015). Comparatively, younger women are
more likely to be diagnosed with triple negative cancers
(Clarke et al., 2012).
Population-based data on cancer incidence has been
collected by the Surveillance, Epidemiology, and End
Results since 1973 and the Centers for Disease Control
and Prevention’s National Program for Cancer Registry
since 1995 (Siegel et al., 2015). SEER, however, is the
only source providing long term delay-adjusted and
population-based incidence data (Siegel et al., 2015). Data
for the nine selected states in this study were provided by
SEER: California, Connecticut, Georgia, Hawaii, Iowa,
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Michigan, New Mexico, Utah and Washington (Siegel et
al., 2015). Using a joint-point regression model based on
cancer incidence between 1997 and 2011, it was estimated
that 231,840 women would be diagnosed with breast
cancer by 2015 and that 40,290 deaths due to breast cancer
would occur in 2015 (Siegel et al., 2015). The incidence
of breast cancer from 2007 to 2011 for each state included
in this paper are as follows: (a) Connecticut had 136.6
cases per 100,000 with a death rate of 20.8, (b) California
had 122.4 cases per 100,000 with a death rate of 21.5, (c)
Georgia had 123.8 cases per 100,000 with a death rate of
23.1, (d) Iowa had 124.8 cases per 100,000 with a death
rate of 20.7, (e) Michigan had 120.7 cases per 100,000
with a death rate of 23.5, (f) Hawaii had 126.0 cases per
100,000 with a death rate of 26.8, (g) New Mexico had
110.0 cases per 100,000 with a death rate of 26.8, (h)
Washington had 132.5 cases per 100,000 with a death rate
of 21.1, and (i) Utah had 112.0 cases per 100,000 with a
death rate of 20.8 (Siegel et al., 2015).
There have been significant declines in breast cancerrelated death rates across the US. From 1997 to 2011,
these declines in cancer death rates ranging from 25 - 30%
occurred in Maryland, New Jersey, Massachusetts, New
York, and Delaware. During the same years, another
20,000 deaths were averted in California due to a 25% drop
in cancer incidence (Siegel et al., 2015). Southern states
appeared to have the slowest declines and western states
showed the lowest death rates (Ning et al., 2015; Siegel
et al., 2015). These differences could reflect disparities in
resources and prevention. In 2011, cancer incidence ranged
from 125.6 cases per 100,000 in Utah to 200.9 cases per
100,000 in Kentucky (Siegel et al., 2015). Model-based
methodology was used to predict breast cancer incidence
and death for 2015. The estimated female breast cancer
cases in 2015 for each of the nine states were as follows:
(a) Hawaii at 1,140 cases, (b) New Mexico at 1,320
cases, (c) Utah at 1,490 cases, (d) Iowa at 2,390 cases,
(e) Connecticut at 3,190 cases, (f) Washington at 5,480
cases, (g) Georgia at 7,170 cases, (h) Michigan at 7,780
cases, and (i) California at 25,270 cases. Additionally, the
estimated female breast cancer deaths per state were as
follows: (a) Hawaii at 130 deaths (b) New Mexico at 270
deaths, (c) Utah at 270 deaths, (d) Iowa at 390 deaths, (e)
Connecticut at 460 deaths, (f) Washington at 830 deaths,
(g) Georgia at 1,240 deaths, (h) Michigan at 1,410 deaths,
and (i) California at 4,320 deaths. Estimated new cancer
cases for women in the US in 2015 were 810,170 cases,
with an estimated 29% attributed to breast cancer. The
estimated cancer deaths for women in 2015 were 277,280,
with an estimated 15% attributed to breast cancer. These
declines in breast cancer incidence and mortality in the
US are a result of prevention efforts and advancement in
medical practices (Siegel et al., 2015).
Breast cancer incidence and mortality also varies
between different ethnicities. From 2007 to 2011, the
incidence of breast cancer was 127.6 cases per 100,000
among White non-Hispanics, 123.0 cases per 100,000
for Black non-Hispanics, 91.7 cases per 100,000 among
American Indians and Alaska Natives, 91.6 cases per
100,000 among Hispanics, and 86.0 cases per 100,000
among Asians and Pacific Islanders. Additionally, the
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death rates among ethnic groups were 11.3 deaths per
100,000 among Asians and Pacific Islanders, 14.5 deaths
per 100,000 among Hispanics, 15.2 deaths per 100,000
among American Indians and Alaska Natives, 22.2 deaths
per 100,000 among White non-Hispanics, and 31.4 deaths
per 100,000 among Black non-Hispanics. The five-year
survival for White women had increased by 16% from 76%
in 1975 to 92% in 2010 and the five-year survival of Black
women increased by 18% from 62% in 1975 to 80% in
2010 (Siegel et al., 2015). However, another study showed
that the frequency of breast cancer decreased among
White non-Hispanic women but increased among Blacks,
Asians, White Hispanics, and American Indians and
Alaska Natives between January of 2000 and December
of 2006 (Ooi et al., 2011). This could be due to numerous
racial disparities. For instance, Blacks are more likely to
receive poor care, face higher levels of poverty, receive a
later stage diagnosis, and encounter lower stage-specific
survival (Siegel et al., 2015). Moreover, the highest risk
of death in Blacks is associated among those with comorbidities. Co-morbidities, as well as disparities between
racial and ethnic groups, are a predictors of survival (Ning
et al., 2015). Black women are more likely to have higher
co-morbidity scores compared to other racial and ethnic
groups, which leads to a high risk of mortality associated
with co-morbidity (Ning et al., 2015).
Compared to White non-Hispanics, other racial and
ethnic groups have been shown to have greater odds of
dying from breast cancer. In one study explaining the role
of race and ethnicity in stage 1 breast cancer diagnosis
and treatment, there were some differences identified.
The majority of breast cancer diagnosis (71%) was seen
in White non-Hispanics (Iqbal et al., 2015). After Whitenon-Hispanics, minority racial and ethnic groups have
the greatest odds of dying from cancer (Ooi et al., 2011).
Japanese women were more likely to be diagnosed at
stage 1 breast cancer compared to Black women who were
diagnosed at later stages (Iqbal et al., 2015). Additionally,
among Asians, the Japanese had lower odds of breast
cancer while Koreans had higher odds (Iqbal et al.,
2015). Black women had the highest proportion of triplenegative breast cancer and were more likely to die within
seven years. Black women had the highest odds of being
diagnosed with estrogen receptor negative/progesterone
receptor negative (ER-/PR-) cancers.
Blacks and White Hispanics had greater odds of
receiving inappropriate surgical and radiation breast
cancer treatment (Ooi et al., 2011). Mexicans, and South
and Central Americans had a greater likelihood of being
diagnosed with stage III or IV breast cancer and of
receiving inappropriate treatment while Puerto Ricans
were more likely to be diagnosed with ER-/PR- cancers
and an increased risk of mortality (Ooi et al., 2011). Of
all racial and ethnic groups, Samoans had greater odds of
receiving inappropriate treatment and were more likely to
be diagnosed at stage IV (Ooi et al., 2011). Overall, Blacks,
Hispanics, Hawaiians, and American Indians presented
with more advanced stages of breast cancer, ER-/PR-,
and mortality from breast cancer (Ooi et al., 2011). Black
women in particular, were adversely affected by lower
utilization of screening and preventative services, poor
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clinical care after subsequent breast cancer diagnosis, poor
long-term follow-up care after an abnormal mammogram,
and clinical management (Ooi et al., 2011 and Siegel et
al., 2015). Alaskan Natives and American Indians were
more likely to be diagnosed with more advanced ER-/
PR- cancers (Siegel et al., 2015).
In a comparative study of 7,375 black women 65 years
and older diagnosed with breast cancer between 1991 to
2005, and 7,375 matched white control patients, 12% of
Blacks compared to 5% of Whites did not receive any care
for their breast cancer (Silber et al., 2013). Also, the mean
age of diagnosis was later for Blacks compared to Whites
(Silber et al., 2013). This can be attributed to Blacks
presenting with decreased health status at diagnosis, more
advanced stages of the disease, worse biological features
of cancer, and co-morbid conditions (Silber et al., 2013).
A study by Kwan et al. (2014) highlights some of the
health disparities other ethnicities experience that could
contribute to breast cancer mortality among these groups.
This study investigated body size and survival categorized
by race/ethnicity in 11,351 cancer patients diagnosed
between 1993 and 2007. Study findings indicated that
obese women were most likely to be African Americans,
Hispanics, older, current and past smokers, less educated,
US born, and living in lower socioeconomic status (SES)
neighborhoods (Kwan et al., 2014). Hispanics, Whites,
Blacks, and Asians tended to live with higher proportions
of the population having less than a high school education
(Ooi et al., 2011). These racial and ethnic groups had 1.5
to 2.4 higher odds of stage IV tumors and the same odds
of being diagnosed with ER-/PR- cancers. Additionally,
obese women were more likely to be diagnosed with
advanced stage, poorly differentiated, and larger tumors
(Kwan et al., 2014). They were also least likely to receive
hormonal therapy and breast cancer surgery (Kwan et
al., 2014). Interestingly, women with the highest and
lowest BMI had a 1.4 greater risk of death by breast
cancer (Kwan et al., 2014). Khan et al. (2014a, b, c, d)
has conducted extensive work with SEER breast cancer
data. These studies examine statistical analyses and
survival probability among breast cancer patients between
various states and ethnicities. The readers are referred to
these works.
It is essential that trends in breast cancer patients’
statistics need to be studied in order to reduce the
prevalence of this disease in the US. The goals of this
study are: (i) to acquire knowledge of descriptive statistics
for some selected demographic and socioeconomic
characteristics surrounding breast cancer incidence,
and (ii) to identify probability-survival models by using
goodness of fit tests for breast cancer patients.

Materials and Methods
Several skewed statistical probability models have
been used for inferential statistics. This study presents
the use of advanced statistical probability models,
including Burr, Wakeby, Gen. Gamma, Gamma, Pearson
6, and Gen. Pareto. Various goodness-of-fit statistics
such as Kolmogorov-Smirnov, Anderson-Darling, and
Chi-Squared were used to determine the best probability

distribution that fits the data.
Survival times from 2,000 breast cancer patients
from each of the nine states (California, Connecticut,
Georgia, Hawaii, Iowa, Michigan, New Mexico, Utah,
and Washington) were used in the statistical data analysis.
SPSS software was (version 21, IBM Inc., Chicago, IL,
US, 2015) used to calculate the descriptive statistics for
the selected socio-demographic variables and the EasyFit
software (2015) was used for the assessment of goodness
of fit testing and to identify the best fit survival models.
Data Source and Selection of Cases
The data for this study were obtained from the National
Cancer Institute’s SEER cancer registry program. The
SEER program collects data through eighteen cancer
registries in the US that are located in San FranciscoOakland SMSA (1973), Connecticut (1973), Metropolitan
Detroit (1973), Hawaii (1973), Iowa (1973), New
Mexico (1973), Seattle (Puget Sound) (1974), Utah
(1973), Metropolitan Atlanta (1975), Alaska (1992), San
Jose-Monterey (1992), Los Angeles (1992), Rural Georgia
(1992), Greater California (excluding San Francisco (SF),
Los Angeles (LA) & San Jose (SJ))(2000), Kentucky
(2000), Louisiana (2000), New Jersey (2000) and Greater
Georgia (excluding Atlanta (AT) and Rural Georgia (RG))
(2000). Data files for breast cancer cases were downloaded
from the SEER website. For this analysis, male breast
cancer cases were excluded and we selected only female
patients diagnosed with primary invasive breast cancer
from years 1973 to 2012. A breakdown of total breast
cancer cases for each registry is shown in Table 1. Breast
cancer by state was our primary exposure of interest,
and we selected individuals residing in the US according
to the demographic information provided in the SEER
(2010) database.
The specific inclusion criteria were as follows: (1)
females; (2) Black, White, Other, and Hispanic race/
ethnicity; (3) age of diagnosis between 18 and 90 years
old; (4) diagnosis between 1973 and 2012 with breast
cancer as the primary cancer diagnosis; (5) AJCC stages I
to IV; (6) known tumor size; and (7) the degree of axillary
lymph node involvement (LN), estrogen receptor (ER)
and progesterone receptor (PR) statuses. Women who
were diagnosed with breast cancer at death or by autopsy
and those with other first primary cancers, in situ disease
and no record of surgery type or radiation therapy were
excluded from this analysis. Patients diagnosed with
incomplete information were also not included.

Results
The total number of breast cancer cases reported
between 1973 and 2012 was 1,385,980 (Table 1). The
largest sample was drawn from the Greater California
(excluding SF, LA and SJ) region with 199,716 (14.4%)
cases and the lowest from Alaska with 1,352 (0.1%) cases.
Among regions where data was available since 1973,
Metropolitan Detroit had the greatest number of reported
breast cancer cases with 123,936 (8.94%) females and
Hawaii reported 31,415 (2.3%) breast cancer cases, which
was lowest among this group. For the purpose of this study,
Asian Pacific Journal of Cancer Prevention, Vol 17
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Table 1. Total Female Breast Cancer Cases (1973-2012)
Cancer Registry

Frequency

Percent (%)

San Francisco-Oakland SMSA (1973)

122,693

8.9

Connecticut (1973)

119,258

8.6

Metropolitan Detroit (1973)

123,936

8.9

Hawaii (1973)

31,415

2.3

Iowa (1973)

89,708

6.5

New Mexico (1973)

39,159

2.8

Seattle (Puget Sound) (1974)

113,129

8.2

Utah (1973)

37,653

2.7

Metropolitan Atlanta (1975)

63,555

4.6

Alaska*

1,352

0.1

San Jose-Monterey*

37,880

2.7

Los Angeles*

138,535

10.0

2,081

0.2

Greater California (excluding SF, Los Angeles & SJ)**

199,716

14.4

Kentucky**

46,703

3.4

Louisiana**

46,514

3.4

New Jersey**

113,531

8.2

Greater Georgia (excluding AT and RG)**

59,162

4.3

1,385,980

100%

Rural Georgia*

Total

(Year in parentheses refers to first diagnosis year data reported to SEER.); *Note,The incidence/yr1992_2012.sj_la_rg_ak directory files contain
cases for Alaska, San Jose-Monterey, Los Angeles and Rural Georgia registries beginning in 1992; Cases have been collected by SEER for these
registries prior to 1992 but have been excluded from the SEER Research Data file; **Note, The incidence/yr2000_2012.ca_ky_lo_nj_ga directory
files contain cases for Greater California, Kentucky, Louisiana, New Jersey and Greater Georgia registries beginning in 2000; For the year 2005,
only January through June diagnoses are included for Louisiana; The July through December incidence cases can be found in the yr2005.lo_2nd_
half directory

we excluded registries that had data only from the year
1990 onwards. The nine registries with data available from
1973 to 2012 included in the analysis were California,
Connecticut, Georgia, Hawaii, Iowa, Michigan, New
Mexico, Utah, and Washington.
A summary of descriptive statistics are shown in
Table 2. The mean age of diagnosis across all nine states
ranged from late 50s to mid-60s. States with the earliest
ages of diagnosis included Georgia at a mean age of 58.0
years (SD = 14.0) and Hawaii with a mean age of 59.7
years (SD = 13.6), while Iowa reported the latest mean
age of diagnosis at age 64.1 years (SD = 14.5). The state
reporting the greatest variance in age of diagnosis was
California with a mean of 61.4 years (SD = 25.2). Across
the nine states, age of diagnosis spanned from ages 16
(Utah) to age 104 (Iowa). Other mean age of diagnosis
were Connecticut at 62.5 years (SD = 14.3), Washington
at 61.5 years (SD = 14.4), New Mexico at 61.3 years (SD
= 14.1), Michigan at 60.98 years (SD = 14.2), and Utah
at 60.8 years (SD = 14.5).
Patients’ survival time was measured in months,
post diagnosis. At approximately 8 years, New Mexico
(105.0 months) and Georgia (105.7 months) reported
the shortest survival time. While California reported the
longest survival time (116.9 months) of almost 9.7 years,
which was followed by Hawaii with a mean survival time
of 114.1 months (9.5 years), and then by Iowa with 113.2
months (9.4 years), Washington 112.0 months (9.3 years),
Connecticut 110.8 months (9.2 years), Michigan 108.2
months (9.0 years), and Utah 107.2 with months (8.93
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years). The maximum patient survival time post diagnosis,
was reported as 467 months (38.9 years) from Michigan.
Marital status was measured as single, married,
separated, divorced, and widowed. California reported the
highest number of single patients at 14.6%, followed by
Georgia at 12.6%, then Connecticut at 11.7%, Michigan at
11.2%, Hawaii at 11%, New Mexico at 10%, Washington
at 8.6%, Iowa at 7.2%, and Utah at 5.9%. The majority of
patients across all of the nine states reported being married.
Utah reported the highest percentage of married patients
at 64.4%, followed by Hawaii at 59.6%, then by Iowa at
58.3%, Washington 58.0%, Georgia 54.8%, New Mexico
54.1%, California 53.1%, Connecticut 52.9%, and finally
Michigan at 50.6%. The state with the highest number
of patients categorized as separated was Connecticut at
4.3%, followed by California 1.3%, Georgia 1%, Hawaii
0.8%, Michigan 0.7%, New Mexico 0.5%, Iowa and
Washington at 0.4%, and Utah 0.3%. Georgia reported the
highest number of participants categorized as divorced at
11.8%, followed by Washington at 10.5%, then Michigan
at 10.2% California at 9.7%, Hawaii 9.3%, Connecticut
8.6%, Utah at 8.3%, New Mexico 8%, and Iowa at 6.9%.
Iowa reported the greatest percentage of widowed patients
at 25.6%, followed by Michigan at 22.7%, then Utah
at 18.9%, Connecticut at 18.8%, California at 18.5%,
New Mexico at 18.2%, Washington at 18.1%, Georgia at
17.1%, and Hawaii at 16.4%.
Most states reported a sample of primarily White
patients (>70.2%) with the exception of Hawaii reporting
a sample of only 30.2% of White patients. Iowa reported
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Table 2. Summary Statistics for Female Breast Cancer Patients of Nine States
Connecticut

61.0

2,000

Michigan

59.7

2,000

Hawaii

64.1

2,000

Iowa

61.3

2,000

New Mexico

61.5

2,000

Washington

60.8

2,000

Utah

58.0

2,000

Georgia

Registry
California

62.5

2,000

Statistics

61.4

2,000

Variables
N (no. of patients)

N (no. of patients)

Maximum

Minimum

Std. Deviation

93.2

116.9

1,987

99.0

24.0

25.2

93.6

110.8

1,989

98.0

25.0

14.3

94.3

108.2

1,991

97.0

22.0

14.2

96.6

114.1

1,999

100.0

24.0

13.6

94.5

113.2

1,992

104.0

23.0

14.5

89.9

105.0

1,983

99.0

17.0

14.1

92.6

112.1

1,992

103.0

26.0

14.4

92.9

107.2

1,995

99.0

16.0

14.5

90.9

105.7

1,990

99.0

23.0

14.0

Age at Diagnosis (years)
Mean

Mean
Minimum
462.0

0.0
459.0

0.0
467.0

0.0

462.0

0.0

458.0

0.0

464.0

0.0

449.0

0.0

459.0

0.0

443.0

0.0

Survival time (months)

Std. Deviation
Maximum
293 (14.6%)

223 (11.2%)

219 (11%)

145 (7.2%)

199 (10%)

171 (8.6%)

6 (0.3%)

1,288 (64.4%)

119 (5.9%)

19 (1%)

1,095 (54.8%)

252 (12.6%)

233 (11.7%)

Single

9 (0.4%)

1,159 (58%)

Marital status

10 (0.5%)

235 (11.8%)

1,082 (54.1%)

165 (8.3%)

57 (2.9%)

342 (17.1%)

8 (0.4%)

210 (10.5%)

44 (2.2%)

378 (18.9%)

1,165 (58.3%)

159 (8%)

90 (4.5%)

361 (18.1%)

15 (0.8%)

138 (6.9%)

186 (9.3%)

364 (18.2%)

1,192 (59.6%)
186 (9.3%)

32 (1.6%)

512 (25.6%)

14 (0.7%)

85 (4.3%)

203 (10.2%)

60 (3%)

328 (16.4%)

1,013 (50.6%)

25 (1.3%)
173 (8.6%)

93 (4.7%)

454 (22.7%)

1,062 (53.1%) 1,059 (52.9%)
193 (9.7%)

75 (3.8%)

375 (18.8%)

Married
Divorced
57 (2.9%)

370 (18.5%)

Separated

Unknown

Widowed

1,563 (78.1%)

604 (30.2%)

1,977 (98.9%)

1,894 (94.7%)

114 (5.7%)

52 (2.6%)

1,833 (91.6%)

40 (2%)

9 (0.4%)

1,945 (97.3%)

34 (1.7%)

560 (28%)

1,403 (70.2%)

1,589 (79.5%) 1,876 (93.8%)

17 (0.9%)

White

83 (4.2%)

Race

2 (0.1%)

3 (0.2%)

18 (0.9%)

6 (0.3%)

1,946 (97.3%)

17 (0.9%)

1 (0.1%)

1,934 (96.7%)

54 (2.7%)

1371 (68.6%)

6 (0.3%)

1,973 (98.7%)

66 (3.3%)

19 (1%)

3 (0.2%)

1,467 (73.4%)

27 (1.4%)

409 (20.5%)

8 (0.4%)

1,992 (99.6%)

533 (26.7%)

9 (0.4%)

9 (0.4%)

1,922 (96.1%)

8 (0.4%)

105 (5.3%)
10 (0.5%)

1,975 (98.8%)

78 (3.9%)

239 (12%)
11 (0.5%)

1,928 (96.4%)

25 (1.3%)

161 (8.1%)

1,860 (93%)

72 (3.6%)

Black

140 (7%)

Other
Unknown
Ethnicity
Non-Hispanic
Hispanic
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Table 3. Goodness of Fit Analysis to Select Best Probability Survival Models
State
California

Connecticut

Georgia

Hawaii

Iowa

Michigan

New Mexico

Utah

Washington

Probability

Kolmogorov

Anderson

Chi

Distribution

Smirnov

Darling

Squared

Burr

0.046

51.7

116.9

Parameter Estimates
k=2.3 α=1.3 β=195.0

Dagum

0.028

43.6

41.5

k=0.3 α=2.9 β=189.9

Wakeby

0.025

1.9

18.2

α=150.6 β=0.4 γ=5.1 δ=0.9 ζ=-1.1

Burr

0.043

43.8

102.1

k=2.7 α=1.2 β=221.8

Dagum

0.028

35.6

16.3

k=0.3 α=2.9 β=191.3

Wakeby

0.018

1.8

10.4

α=133.1 β=0.1 γ=0.1 δ=0.1 ζ=-2.1
k=2.6 α=1.2 β=204.6

Burr

0.039

57.8

97.5

Dagum

0.031

50.6

26.8

k=0.3 α=2.8 β=175.3

Wakeby

0.016

1.1

8.8

α=126.1 β=0.2 γ=1.4 δ=0.1 ζ=-1.1

Gamma

0.029

92.4

37.2

α=1.1 β=110.0

Gen Pareto

0.027

82.0

NA*

k=-0.1 s=126.2 m=0.8

Wakeby

0.027

82.0

NA*

α=126.2 β=0.1 γ=0 δ=0 ζ=0.8

Burr

0.033

58.5

60.4

k=2.9 α=1.3 β=239.5

Gen Gamma

0.029

51.2

20.5

k=1.7 α=0.5 β=199.9

Wakeby

0.013

0.8

7.5

α=139.2 β=0.2 γ=1.9 δ=0.9 ζ=-1.3

Dagum

0.046

69.4

97.8

k=0.3 α=2.8 β=184.1

Pearson 6

0.045

69.4

91.6

a1=1.3 α2=3.9 β=288.3

Burr

0.038

62.9

39.7

k=2.8 α=1.2 β=223.8

Burr

0.047

89.5

146.1

k=2.0 α=1.2 β=159.7

Dagum

0.033

80.1

53.0

k=0.4 α=2.5 β=166.8

Wakeby

0.030

3.6

34.6

α=123.3 β=0.3 γ=6.6 δ=0.9 ζ=-2.8

Dagum

0.037

47.3

66.2

k=0.3 α=3.1 β=186.7

Burr

0.035

43.5

25.7

k=3.7 α=1.2 β=293.1

Gen Gamma

0.030

42.2

22.1

k=1.6 α=0.5 β=188.2

Burr

0.041

56.5

85.3

k=3.0 α=1.3 β=243.4

Dagum

0.035

49.3

26.6

k=0.3 α=3.2 β=195.9

Gen Gamma

0.031

47.7

15.2

k=1.9 α=0.5 β=207.9

*Note, Probability distribution could not be determined by the software

the highest number of White patients at 98.9%, followed
by Utah at 97.3%, New Mexico 94.7%, Connecticut
93.8%, Washington 91.6%, California 79.5%, Michigan
78.1%, and Georgia 70.2%. Georgia reported the highest
number of Black patients at 28% followed by Michigan
at 20.5%, California at 8.1%, Connecticut at 5.3%,
Washington at 2.6%, Hawaii, Iowa and New Mexico
reported 0.9%, and Utah at 0.4%. In Hawaii, 68.6% of
patients were categorized as “other”, followed by 12%
in California, 5.7% in Washington, 4.2% in New Mexico,
2% in Utah, 1.7% in Georgia, 1% in Michigan, 0.4% in
Connecticut, and 0.1% in Iowa.
Ethnicity was categorized as Hispanic or non-Hispanic.
Most participants were categorized as non-Hispanic,
with New Mexico reporting the lowest number of
non-Hispanic patients at 73.4%. New Mexico was followed
by California which reported 93% of non-Hispanic patients,
then by Hawaii at 96.1%, Connecticut at 96.4%, Utah at
96.7%, Georgia at 97.3%, Washington at 98.7%, Michigan
at 98.8%, and Iowa at 99.6%. New Mexico reported the
highest number of Hispanic patients at 26.7% followed
by California at 7%, Hawaii 3.9%, Connecticut at 3.6%,
Utah 3.3%, Georgia at 2.7%, Washington 1.4%, Michigan

5292

Asian Pacific Journal of Cancer Prevention, Vol 17

1.3%, and Iowa 0.4%.
The primary variable of interest was survival time (in
months). The survival time was stratified by state registry
and was imported into the EasyFit (2015) software to
compare various statistical probability distributions that
best fit the survival time data for each state. EasyFit (2015)
builds the best fitting probability distribution based on the
data and allows a large number of distributions to the data
to fit. Variables that were included in our analyses were
limited to those that are available in the SEER database.
SPSS software, version 21 (2014) was used for all of the
analyses.
Results from the goodness-of-fit analysis for the
probability distributions from the software (Easyfit,
2015) are summarized in Table 3 as state or name of
the registry, distribution name, Kolmogorov-Smirnov
statistic, Anderson-Darling statistic, Chi-square value,
and parameter values. The probability distributions
identified by EasyFit were namely Burr, Dagum, Wakeby,
Gamma, Gen. Pareto, Gen. Gamma, and Pearson 6. The
three most commonly reported probability distributions
were Burr, Dagum, and Wakeby. The data from eight out
of nine registries was found to fit the Burr distribution

DOI:10.22034/APJCP.2016.17.12.5287
Goodness of Fit for Patients Data

(California, Connecticut, Georgia, Iowa, Michigan, New
Mexico, Utah, and Washington). New Mexico showed
the highest Chi-square value among these groups for Burr
distribution (146.1), the highest Kolmogorov-Smirnov
value (0.04674), and the highest Anderson-Darling value
(89.495). For the same distribution, Iowa had the lowest
Chi-square value (60.38) and Kolmogorov-Smirnov value
(0.03358), while Connecticut had the lowest Anderson
Darling value (43.7). Data from seven registries fit the
Dagum distribution (California, Connecticut, Georgia,
Michigan, New Mexico, Utah, and Washington). For
Dagum distribution, Michigan had the highest Chi-square
value (97.8) and the highest Kolmogorov-Smirnov
value (0.04643), whereas New Mexico had the highest
Anderson-Darling value (80.1). The lowest values among
the Dagum distribution included the Chi-squared value
(16.33) and the Anderson-Darling value (35.636) for
Connecticut and the Kolmogorov-Smirnov value for
California (0.02799). Data from six registries fit Wakeby
distribution (California, Connecticut, Georgia, Hawaii,
Iowa, and New Mexico). New Mexico also had the
highest Chi-square value (34.62), Kolmogorov-Smirnov
value (0.03012) and Anderson-Darling value (3.6187)
for Wakeby distribution, while Iowa had the lowest
Chi-squared value (7.53), Kolmogorov-Smirnov value
(0.01344), and Anderson-Darling value (0.83923). Utah
also had the highest Chi-squared value (22.064) for Gen.
Gamma distribution, and Washington had the lowest
value (15.2). The Wakeby and Gen. Pareto distribution’s
Chi-square goodness of fit statistic for Hawaii was not
available.

Discussion
Breast cancer remains a serious women’s health
and public health issue across the world and in the U.S.
With millions of women predicted to be affected by this
disease in the future, it is essential that more research
over the epidemiology of this disease be addressed. Of
particular interest are what groups of women (White,
Black, Hispanic, Non-Hispanic, single, married, separated,
divorced, widowed) are at higher risk of developing breast
cancer and their respective survival times. Through our
analysis of nine state registries with SEER (California,
Connecticut, Georgia, Hawaii, Iowa, Michigan, New
Mexico, Utah, and Washington) this study addressed
descriptive statistics for each of the nine registries, as well
as investigating the goodness-of-fit of possible probability
models for breast cancer patient survival. Based on our
findings, the Burr model fit six out of the nine registries
being analyzed, with New Mexico showing the highest
Chi-squared goodness-of-fit value at 146.09. Dagum
probability model best fits for Michigan and Utah. Gamma
probability model best fits for Hawaii. Additionally,
California reported a mean survival of almost 9.74 years
while New Mexico and Georgia reported a mean survival
of almost 8 years. Clearly there are healthcare disparities
that are influencing a gap of almost 2 years in breast cancer
survival time post diagnosis.
It is imperative that future studies address possible
policies, prevention programs, and healthcare disparities

that could influence the rates of breast cancer incidence
and mortality. Future studies could address the level of
breast cancer education that breast cancer patients received
prior to their diagnosis and during their diagnosis; this will
aid in determining if the lack of breast cancer education
pre-diagnosis is a leading factor in the lack of patients
seeking out preventive screenings biannually. Further
studies could also address how easily accessible women’s
health care centers are in different urban and rural areas.
If women living in more rural areas compared to urban
or suburban areas have later stage primary breast cancer
diagnosis, or potentially shorter lifespans post diagnosis,
this could indicate an issue in accessibility of care.
These studies would address the availability to effective
prevention programs. Socio-economic factors, as well
as racial and ethnic discrimination, can be evaluated to
gain more precise data on which groups of women are
suffering from health care disparities leading to poor
breast cancer screening rates and decreased survival
time post-diagnosis. Understanding these contributing
factors is necessary in order to create state-specific and
population-specific programs and methods to decrease the
prevalence of breast cancer as well as increase survival
time post-diagnosis across all states in the United States.
SEER has collected cancer data for over thirty years
from cancer registries throughout the United States; it is
nationally recognized and considered a reliable source
of information on incidence, mortality, and other related
variables. Although the use of SEER lends this study
strength, it is limited in the information it can provides.
This studied is also limited by the length of time that
is considered in this data set. It would be interesting
future work for further analysis to be conducted for the
states (California, Connecticut, Georgia, Iowa, New
Mexico, and Washington) by splitting the data sets into
multiple categories since there are numerous factors
such as medical improvements, modern technology, and
environmental changes which may influence the breast
cancer survival probability. SEER lacks insight into many
variables, such as social and economic factors that affect
the survival time of breast cancer patients. Additionally,
only data after the year 1992 was used for Alaska, San
Jose-Monterey, Los Angeles, and Rural Georgia registries
due to SEER excluding the cases prior to 1992 from the
SEER Research Data file. Furthermore, only data after
the year 2000 was used for Greater California, Kentucky,
Louisiana, New Jersey, and Greater Georgia registries
due to SEER excluding the cases prior to 2000 from the
SEER Research Data file. For the year 2005, only January
through June diagnoses were included for Louisiana in the
SEER Research Data file.
The present study included some variables from
SEER data, such as age at diagnosis, survival times,
marital status, race, and ethnicity. For future studies
socioeconomic factors may be considered to investigate
disparities associated with breast cancer since they vary
geographically according to different health policies.
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